机构:[a]Peking University Fifth School of Clinical Medicine, Beijing, 100730, China[b]The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, P.R. China, Beijing, 100730, China[c]Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China首都医科大学附属天坛医院
This study was supported by grants from the National Natural Science Foundation of China (grant no. 81770228 , 81470427 , 31400995 and 81770858 ), Beijing Natural Science Foundation (grant no. 7142142 , 7154234 ), Beijing Hospital Nova project (grant no. BJ-2016-045 , BJ-2016-034 , BJ-2018-138 , BJ-2016-032 ), and Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences ( 2018RC310025 ), Special Subsidy Project of Beijing Municipal Science and Technology Commission on the Application Research of Capital Clinical Characteristics (grant no. Z181100001718138 ).
语种:
外文
中科院(CAS)分区:
出版当年[2018]版:
大类|3 区生物
小类|3 区生物物理4 区生化与分子生物学
最新[2023]版:
大类|3 区生物学
小类|3 区生物物理4 区生化与分子生物学
第一作者:
推荐引用方式(GB/T 7714):
Yu X,Ruan Y,Huang X,et al.Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes[J].BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2019,doi:10.1016/j.bbrc.2019.12.027.
APA:
Yu, X,Ruan, Y,Huang, X,Dou, L,Lan, M...&Shen, T.(2019).Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,,
MLA:
Yu, X,et al."Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes".BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS .(2019)